Conclusions To summarize, the 68-week treatment with coadministered cagrilintide and semaglutide resulted in substantial and clinically meaningful weight loss in adults with overweight or obesity, significantly outperforming monotherapies and placebo (- 5.5% vs
A B12 injection is a viable treatment option for anyone displaying signs of Vitamin B12 deficiencies, such as fatigue and weakness, mood swings, memory loss, inability to walk, or muscle cramps
doi: 10.1016/j.ejmech.2020.112193 195 TsilimigrasD
While generally safe, individuals should consult their healthcare provider before starting IM injections, especially if they have pre-existing health conditions or allergies
described a 51-year-old man diagnosed with WD based on abnormal copper metabolism, liver function test results, and the presence of the KF ring